Jennifer Sanfilippo
Compliance Officer at MELINTA THERAPEUTICS, INC.
Profile
Jennifer A.
Sanfilippo is currently the Chief Executive Officer at Rempex Pharmaceuticals, Inc. and the Chief Compliance Officer & General Counsel at Melinta Therapeutics, Inc. Previously, she worked as an Attorney at Porzio, Bromberg & Newman PC.
She completed her undergraduate degree at New York University and her graduate degree at Rutgers Law School.
Jennifer Sanfilippo active positions
Companies | Position | Start |
---|---|---|
MELINTA THERAPEUTICS, INC. | Compliance Officer | - |
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Chief Executive Officer | - |
Former positions of Jennifer Sanfilippo
Companies | Position | End |
---|---|---|
Porzio, Bromberg & Newman PC
Porzio, Bromberg & Newman PC Miscellaneous Commercial ServicesCommercial Services Porzio, Bromberg & Newman PC provides legal services. Its practice area include bankruptcy, data privacy and cyber security, FDA, litigation, real estate and intellectual property. The company was founded in 1962 and is headquartered in Morristown, NJ. | Corporate Officer/Principal | - |
Training of Jennifer Sanfilippo
New York University | Undergraduate Degree |
Rutgers Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Porzio, Bromberg & Newman PC
Porzio, Bromberg & Newman PC Miscellaneous Commercial ServicesCommercial Services Porzio, Bromberg & Newman PC provides legal services. Its practice area include bankruptcy, data privacy and cyber security, FDA, litigation, real estate and intellectual property. The company was founded in 1962 and is headquartered in Morristown, NJ. | Commercial Services |
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Health Technology |
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
- Stock Market
- Insiders
- Jennifer Sanfilippo